Kathleen Frybarger
Psychiatric/Mental Health · Clarkston, MINPI 1306476809
Payments from drug & device makers
Across 336 payments — averaging $14.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$863
- Otsuka America Pharmaceutical, Inc.$567
- Alkermes, Inc.$478
- Teva Pharmaceuticals USA, Inc.$418
- Corium, LLC$394
- Supernus Pharmaceuticals, Inc.$385
- plus $2K from 13 others
What the payments were for
- Food & beverage$4,95399%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 72 | $863 |
| Otsuka America Pharmaceutical, Inc. | 32 | $567 |
| Alkermes, Inc. | 23 | $478 |
| Teva Pharmaceuticals USA, Inc. | 41 | $418 |
| Corium, LLC | 20 | $394 |
| Supernus Pharmaceuticals, Inc. | 28 | $385 |
| AbbVie | 28 | $347 |
| Ironshore Pharmaceuticals Inc. | 27 | $342 |
| Johnson & Johnson | 14 | $280 |
| Neurocrine Biosciences, Inc. | 12 | $248 |
| Lundbeck LLC | 12 | $220 |
| Sunovion Pharmaceuticals Inc. | 9 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $130 |
| Tempus AI, Inc | 2 | $49 |
| Noven Therapeutics, LLC | 2 | $39 |
| Biogen | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Brainsway USA Inc | 1 | $12 |
How this compares
$5,008 in reported general payments places this provider in the 85th percentile of 638 psychiatric/mental health providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 38 | $53,879 |
| CaplytaLumateperone Tosylate | 28 | $44,088 |
| VraylarCariprazine Hcl | 21 | $28,302 |
| TrintellixVortioxetine Hydrobromide | 38 | $19,667 |
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $17,207 |
| Aripiprazole | 33 | $3,366 |
| Lurasidone Hcl | 40 | $1,626 |
| Prazosin Hcl | 91 | $1,071 |
| Quetiapine Fumarate | 63 | $1,061 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 23 | $983 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $745 |
| Fluoxetine Hcl | 37 | $664 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $607 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 19 | $499 |
| Trazodone Hcl | 45 | $444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $567 | $53,87938 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $863 | $44,08828 claims |
| AbbVieVraylar | $347 | $28,30221 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $130 | $19,66738 claims |
| Axsome Therapeutics, Inc.Auvelity | $17 | $17,20719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 638 psychiatric/mental health providers in Michigan.
Other psychiatric/mental health in Clarkston
- Shiba NixonClarkston$60K
- Cody ShinavierClarkston$41K
- Katherine WindrimClarkston$11K
- Mayche Vang-KueClarkston$6K
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Amy AmesClinton Township$43K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.